Clinical Study Evaluating Beta Blockers Use & Fracture Risk in Patients

Clinical Trial Description

Clinical study evaluating selective or nonselective beta blockers use and if there is fracture risk in patients with primary osteoporosis ;

Study Design

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT05106179` - The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma	Phase 4

See also

Status

Clinical Trial

Phase

Enrolling by invitation

NCT05106179 - The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04704947
Study type	Interventional
Source	Tanta University
Contact	Sherief Abd-Elsalam, ass. prof.
Phone	00201147773440
Email	sheriefabdelsalam@yahoo.com
Status	Recruiting
Phase	Phase 3
Start date	October 1, 2017
Completion date	October 1, 2030

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms